Cyclophosphamide and cisplatin versus paclitaxel and cisplatin: A phase III randomized trial in patients with suboptimal stage III/IV ovarian cancer (from the Gynecologic Oncology Group)

被引：0
|
作者：
McGuire, WP
Hoskins, WJ
Brady, MF
Kucera, PR
Partridge, EE
Look, KY
ClarkePearson, DL
Davidson, M
机构：
[1] EMORY UNIV, DEPT MED, ATLANTA, GA 30322 USA
[2] MEM SLOAN KETTERING CANC CTR, DEPT SURG, GYNECOL SERV, NEW YORK, NY 10021 USA
[3] CORNELL UNIV, COLL MED, DEPT OBSTET & GYNECOL, NEW YORK, NY USA
[4] ROSWELL PK CANC INST, GYNECOL ONCOL GRP, STAT OFF, BUFFALO, NY USA
[5] OREGON HLTH SCI UNIV, DEPT OBSTET & GYNECOL, DIV GYNECOL ONCOL, PORTLAND, OR 97201 USA
[6] UNIV ALABAMA, DEPT OBSTET & GYNECOL, DIV GYNECOL ONCOL, BIRMINGHAM, AL 35294 USA
[7] INDIANA UNIV, SCH MED, DIV OBSTET & GYNECOL, INDIANAPOLIS, IN USA
[8] DUKE UNIV, SCH MED, DEPT OBSTET & GYNECOL, DIV GYNECOL ONCOL, DURHAM, NC 27706 USA
[9] WALTER REED ARMY MED CTR, DEPT PATHOL & AREA LAB SCI, WASHINGTON, DC 20307 USA
来源：
SEMINARS IN ONCOLOGY | 1996年 / 23卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：40 / 47
页数：8
相关论文
共 50 条
  • [21] The prognostic value of ERCC1 expression in patients with stage III epithelial ovarian cancer treated with cisplatin and paclitaxel: A Gynecologic Oncology Group study
    Rubatt, J.
    Darcy, K.
    Tian, C.
    Muggia, F.
    Dhir, R.
    Armstrong, D.
    Niedernhofer, L.
    Krivak, T.
    GYNECOLOGIC ONCOLOGY, 2010, 116 (03) : S160 - S160
  • [22] A phase III randomized trial of cisplatin and paclitaxel administered by either 24 hour or 96 hour infusion in patients with selected stage III or stage IV epithelial ovarian cancer (GOG 162).
    Spriggs, DR
    Brady, M
    Rubin, S
    Hanley, M
    Copeland, LJ
    Clarke-Pearson, D
    Burger, R
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 450S - 450S
  • [23] Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer
    Alberts, DS
    Liu, PY
    Hannigan, EV
    OToole, R
    Williams, SD
    Young, JA
    Franklin, EW
    ClarkePearson, DL
    Malviya, VK
    DuBeshter, B
    Adelson, MD
    Hoskins, WJ
    NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (26): : 1950 - 1955
  • [24] RESULTS OF A SOUTHWEST-ONCOLOGY-GROUP PHASE-III TRIAL OF CARBOPLATIN PLUS CYCLOPHOSPHAMIDE VERSUS CISPLATIN PLUS CYCLOPHOSPHAMIDE IN ADVANCED OVARIAN-CANCER
    HANNIGAN, EV
    GREEN, S
    ALBERTS, DS
    OTOOLE, R
    SURWIT, E
    ONCOLOGY, 1993, 50 : 2 - 9
  • [25] Quality of life (QOL) outcomes from a randomized trial of cisplatin versus cisplatin plus paclitaxel in advanced cervical cancer: A Gynecologic Oncology Group study
    McQuellon, Richard P.
    Thaler, Howard T.
    Cella, David
    Moore, David H.
    GYNECOLOGIC ONCOLOGY, 2006, 101 (02) : 296 - 304
  • [26] Phase III trial of standard-dose intravenous cisplatin plus paclitaxel versus moderately high-dose carboplatin followed by intravenous paclitaxel and intraperitoneal cisplatin in small-volume stage III ovarian carcinoma: An intergroup study of the Gynecologic Oncology Group, Southwestern Oncology Group, and Eastern Cooperative Oncology Group
    Markman, M
    Bundy, BN
    Alberts, DS
    Fowler, JM
    Clark-Pearson, DL
    Carson, LF
    Wadler, S
    Sickel, J
    JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (04) : 1001 - 1007
  • [27] Randomized phase III trial of cisplatin with or without topotecan in carcinoma of the uterine cervix: A gynecologic oncology group study
    Long, HJ
    Bundy, BN
    Grendys, EC
    Benda, JA
    McMeekin, DS
    Sorosky, J
    Miller, DS
    Eaton, LA
    Fiorica, JV
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (21) : 4626 - 4633
  • [28] Prospective sequential trials of induction weekly cisplatin followed by monthly cisplatin, doxorubicin, cyclophosphamide and paclitaxel and cisplatin in optimal (≤1 cm) stage III and IV ovarian cancer
    Piver, MS
    Eltabbakh, GH
    Hempling, RE
    Recio, FO
    Blumenson, LE
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 1998, 19 (01) : 5 - 10
  • [29] Exploratory phase III study of paclitaxel and cisplatin versus paclitaxel and carboplatin in advanced ovarian cancer
    Neijt, JP
    Engelholm, SA
    Tuxen, MK
    Sorensen, PG
    Hansen, M
    Sessa, C
    de Swart, CAM
    Hirsch, FR
    Lund, B
    van Houwelingen, HC
    JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (17) : 3084 - 3092
  • [30] Liposomal cisplatin combined with paclitaxel versus cisplatin and paclitaxel in non-small-cell lung cancer: a randomized phase III multicenter trial
    Stathopoulos, G. P.
    Antoniou, D.
    Dimitroulis, J.
    Michalopoulou, P.
    Bastas, A.
    Marosis, K.
    Stathopoulos, J.
    Provata, A.
    Yiamboudakis, P.
    Veldekis, D.
    Lolis, N.
    Georgatou, N.
    Toubis, M.
    Pappas, Ch
    Tsoukalas, G.
    ANNALS OF ONCOLOGY, 2010, 21 (11) : 2227 - 2232
12345